Company profile: HeartHero
1.1 - Company Overview
Company description
- Provider of portable automated external defibrillator technology and companion mobile app. HeartHero's Elliot AED is designed for non-medical users and offers audio/visual prompts, multilingual support, and connectivity for remote monitoring and post-event data access. The HeartHero App connects to the AED to monitor device status, manage settings, access training videos, and order replacement supplies.
Products and services
- Automated External Defibrillator Development: HeartHero architects custom-engineered AEDs enabling anyone, anywhere to respond to sudden cardiac arrest with accessible operation, extending lifesaving reach beyond medical professionals
- Elliot AED: A public-access, portable defibrillator engineered for non-medical users, delivering audio and visual prompts, multilingual guidance, and connectivity for remote monitoring plus post-event data access
- HeartHero App: A mobile-native companion that connects with the Elliot AED to monitor device status, manage settings, access training videos, and order replacement supplies for readiness
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HeartHero
Cardiol Therapeutics
HQ: Canada
Website
- Description: Provider of cannabidiol-based therapies for heart disease, including CardiolRx, an oral solution in clinical development to inhibit inflammatory pathways; CRD-38, a subcutaneous formulation for heart failure aiming to improve pharmacokinetics and therapeutic efficacy; and Phase II studies MAvERIC-Pilot (recurrent pericarditis) and ARCHER (acute myocarditis) evaluating safety, tolerability, efficacy, and impact on myocardial recovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiol Therapeutics company profile →
Valencia Technologies
HQ: United States
Website
- Description: Provider of implantable neuromodulation solutions for urge urinary incontinence, including eCoin, a coin-sized neurostimulator implanted subcutaneously in the lower leg that delivers automatic intermittent tibial nerve stimulation to reduce symptoms, and the eCoin Physician Qualification training program to certify physicians to offer eCoin therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valencia Technologies company profile →
Celladon
HQ: United States
Website
- Description: Provider of biotechnology focused on developing molecular therapies for the treatment of heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celladon company profile →
Invatec
HQ: United States
Website
- Description: Provider of interventional coronary and peripheral products, focused on the development and commercialization of research-driven technologies. Headquartered in Europe, the company collaborates with physicians and centers of excellence to create products aimed at improving life expectancy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invatec company profile →
HeartBeam
HQ: United States
Website
- Description: Provider of a 3D-vector electrocardiogram (VECG) platform for remote cardiac monitoring and 12-lead ECG generation. Offerings include HeartBeam AIMIGo, a portable credit card-sized device that captures and converts heart electrical signals to a 12-lead ECG; core VECG technology delivering diagnostic and prognostic insights; HeartBeam Cloud Service for analysis and on-call physician review; and the AIMIGo App guiding recording and transmission.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HeartBeam company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HeartHero
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HeartHero
2.2 - Growth funds investing in similar companies to HeartHero
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HeartHero
4.2 - Public trading comparable groups for HeartHero
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →